Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in the ...
Fungi-based inks work with polymer decomposers to turn whatever it’s printed on into a self-decomposing productfollowing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback